Susan Domchek
{{short description|American oncologist}}
Susan M. Domchek is an oncologist at the University of Pennsylvania, Executive Director of the Basser Center for BRCA, the Basser Professor in Oncology at the Perelman School of Medicine, and Director of the Mariann and Robert MacDonald Cancer Risk Evaluation Program at Penn Medicine.{{Cite news|url=https://www.nytimes.com/2018/03/06/well/fda-brca-home-testing.html|title=F.D.A. Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats|last=Rabin|first=Roni Caryn|date=2018-03-06|work=The New York Times|access-date=2019-04-05|language=en-US|issn=0362-4331}}{{Cite web|title=Home {{!}} Basser Center|url=https://www.basser.org/|access-date=2021-08-24|website=www.basser.org}} She has authored more than 250 articles in scholarly journals. In 2018, Domchek was elected to the National Academy of Medicine.
Career
In 2011, she led the organization of the international team of physician scientists known as BRCA-TAC, which led a charge to advance clinical testing of olaparib in cancer patients with known inherited mutations in BRCA1 and BRCA2.{{Cite web|last=|first=|date=|title=FORCE Announces 2018 Spirit of Empowerment Awards Recipients|url=https://www.facingourrisk.org/about-ust/our-impact/media-center/assets/Spirit-of-Empowerment-2018-Press-Release.pdf|access-date=|website=Facing Our Risk of Cancer Empowered}} Cancers that are associated with BRCA1 and BRCA2 include breast cancer in men and women, ovarian cancer, melanoma, prostate and pancreatic cancer.{{Cite web|last=Mackin-Solomon|first=Ashley|date=2018-07-26|title=Panel on BRCA genes in La Jolla explains cancer risks|url=https://www.lajollalight.com/news/health-science/sd-lawrence-family-jcc-hosts-brca-forum-20180724-story.html|access-date=2019-04-05|website=lajollalight.com|language=en-US}}
In 2012, Domchek was named Executive Director of the Basser Center for BRCA at Penn Medicine's Abramson Cancer Center.{{Cite web|title=About the Basser Center {{!}} Basser Center|url=https://www.basser.org/about-us|access-date=2021-08-24|website=www.basser.org}} In 2015, Domchek was awarded the William Osler Patient Oriented Research Award for her clinical research in breast cancer genetics.{{cite web |title=2015 Perelman School of Medicine Awards of Excellence |url=https://almanac.upenn.edu/articles/2015-perelman-school-of-medicine-awards-of-excellence |website=almanac.upenn.edu |accessdate=April 5, 2019 |date=November 17, 2015}} In 2018, Domchek was elected to the National Academy of Medicine{{cite web|date=October 15, 2018|title=Four Penn Faculty Members Elected to National Academy of Medicine|url=https://www.pennmedicine.org/news/news-releases/2018/october/four-penn-faculty-members-elected-to-national-academy-of-medicine|website=pennmedicine.org|accessdate=April 5, 2019}} and was honored with the 2018 Spirit of Empowerment by the non-profit organization Facing Our Risk of Cancer Empowered.
References
{{Reflist}}
{{Authority control}}
{{DEFAULTSORT:Domchek, Susan}}
Category:American women oncologists
Category:American women scientists
Category:University of Pennsylvania faculty
Category:Year of birth missing (living people)
Category:American women academics